These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 17166986

  • 1. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A, Passannante M, Kojakali F, Hayden C, Reichman LB.
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [Abstract] [Full Text] [Related]

  • 2. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.
    Arch Intern Med; 2006 Sep 25; 166(17):1863-70. PubMed ID: 17000943
    [Abstract] [Full Text] [Related]

  • 3. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J, Aiona K, Haas M, Reves R, Young J, Belknap R.
    Pediatr Infect Dis J; 2018 Mar 25; 37(3):224-228. PubMed ID: 28777204
    [Abstract] [Full Text] [Related]

  • 4. Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs.
    Ronald LA, FitzGerald JM, Bartlett-Esquilant G, Schwartzman K, Benedetti A, Boivin JF, Menzies D.
    Eur Respir J; 2020 Mar 25; 55(3):. PubMed ID: 31980498
    [Abstract] [Full Text] [Related]

  • 5. Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens.
    Cruz AT, Starke JR.
    Pediatrics; 2018 Feb 25; 141(2):. PubMed ID: 29363561
    [Abstract] [Full Text] [Related]

  • 6. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
    Huang YW, Yang SF, Yeh YP, Tsao TC, Tsao SM.
    Medicine (Baltimore); 2016 Aug 25; 95(34):e4126. PubMed ID: 27559940
    [Abstract] [Full Text] [Related]

  • 7. Treatment of latent tuberculosis infection: An update.
    Lobue P, Menzies D.
    Respirology; 2010 May 25; 15(4):603-22. PubMed ID: 20409026
    [Abstract] [Full Text] [Related]

  • 8. Improved treatment completion with shorter treatment regimens for latent tuberculous infection.
    Macaraig MM, Jalees M, Lam C, Burzynski J.
    Int J Tuberc Lung Dis; 2018 Nov 01; 22(11):1344-1349. PubMed ID: 30355415
    [Abstract] [Full Text] [Related]

  • 9. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
    McNeill L, Allen M, Estrada C, Cook P.
    Chest; 2003 Jan 01; 123(1):102-6. PubMed ID: 12527609
    [Abstract] [Full Text] [Related]

  • 10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 01; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 11. Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.
    McClintock AH, Eastment M, McKinney CM, Pitney CL, Narita M, Park DR, Dhanireddy S, Molnar A.
    BMC Infect Dis; 2017 Feb 14; 17(1):146. PubMed ID: 28196479
    [Abstract] [Full Text] [Related]

  • 12. Successful use of rifampicin for Hispanic foreign-born patients with latent tuberculosis infection.
    Haley CA, Stephan S, Vossel LF, Sherfy EA, Laserson KF, Kainer MA.
    Int J Tuberc Lung Dis; 2008 Feb 14; 12(2):160-7. PubMed ID: 18230248
    [Abstract] [Full Text] [Related]

  • 13. Assessing the impact of patient self-selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin.
    Fluegge KR.
    J Eval Clin Pract; 2014 Oct 14; 20(5):685-91. PubMed ID: 25087583
    [Abstract] [Full Text] [Related]

  • 14. Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis.
    Haas MK, Aiona K, Erlandson KM, Belknap RW.
    Clin Infect Dis; 2021 Nov 02; 73(9):e3459-e3467. PubMed ID: 32915203
    [Abstract] [Full Text] [Related]

  • 15. Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: A systematic review and meta-analysis.
    Tseng SY, Huang YS, Chang TE, Perng CL, Huang YH.
    J Chin Med Assoc; 2021 Nov 01; 84(11):993-1000. PubMed ID: 34747900
    [Abstract] [Full Text] [Related]

  • 16. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
    Chan PC, Yang CH, Chang LY, Wang KF, Lu BY, Lu CY, Shao PL, Hsueh PR, Fang CT, Huang LM.
    Int J Tuberc Lung Dis; 2012 May 01; 16(5):633-8. PubMed ID: 22410137
    [Abstract] [Full Text] [Related]

  • 17. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM, Christenson JC, Downs SM.
    Pediatrics; 2009 Mar 01; 123(3):816-22. PubMed ID: 19255008
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
    Kwara A, Herold JS, Machan JT, Carter EJ.
    Chest; 2008 Apr 01; 133(4):862-8. PubMed ID: 18071014
    [Abstract] [Full Text] [Related]

  • 19. Completion Rates, Adverse Effects, and Costs of a 3-Month and 9-Month Treatment Regimen for Latent Tuberculosis Infection in California Inmates, 2011-2014.
    Wheeler C, Mohle-Boetani J.
    Public Health Rep; 2019 Apr 01; 134(1_suppl):71S-79S. PubMed ID: 31059418
    [Abstract] [Full Text] [Related]

  • 20. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
    Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE.
    Am J Respir Crit Care Med; 2006 Apr 15; 173(8):922-6. PubMed ID: 16474028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.